The American Journal of Surgery
Volume 198, Issue 5 , Pages 645-649 , November 2009

Subintimal placement of covered stent versus subintimal balloon angioplasty in the treatment of long-segment superficial femoral artery occlusion

Received 6 May 2009 ,Revised 24 July 2009

References 

  1. Bolia A, Brennan J, Bell PR. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol. 1989;40:325
  2. Scott EC, Biuckians A, Light RE, et al. Subintimal angioplasty for the treatment of claudication and critical limb ischemia: 3-year results. J Vasc Surg. 2007;46:959–964
  3. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934
  4. Currie IC, Wakeley CJ, Cole SE, et al. Femoropopliteal angioplasty for severe limb ischaemia. Br J Surg. 1994;81:191–193
  5. Lammer J. Femoropopliteal artery obstructions: from the balloon to the stent-graft. Cardiovasc Interv Radiol. 2001;24:73–83
  6. Lofberg AM, Karacagil S, Ljungman C, et al. Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg. 2001;34:114–121
  7. Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft. J Endovasc Ther. 2003;10:619–628
  8. Daenens K, Maleux G, Fourneau I, et al. Hemobahn stent-grafts in the treatment of femoropopliteal occlusive disease. J Cardiovasc Surg. 2005;46:25–29
  9. McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2009;49:109–116
  10. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303–311
  11. Saxon RR, Dake MD, Volgelzang RL, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol. 2008;19:823–832
  12. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67
  13. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD) (TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)). J Vasc Surg. Jan 2000;31(1 Pt 2):S1–S296
  14. Fischer M, Schwabe C, Schulte KL. Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther. 2006;13:281–290
  15. Saxon RR, Coffman JM, Gooding JM, et al. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol. 2007;18:1341–1350
  16. Kedora J, Hohmann S, Garrett W, et al. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg. 2007;45:10–16

PII: S0002-9610(09)00444-9

doi: 10.1016/j.amjsurg.2009.07.017

The American Journal of Surgery
Volume 198, Issue 5 , Pages 645-649 , November 2009

Article Tools

* Image Usage & Resolution